Mazen Abdalla Rasheed, Vinícius Remus Ballotin, Lucas Goldmann Bigarella, Jonathan Soldera
{"title":"Post-COVID-19 cholangiopathy: Systematic review.","authors":"Mazen Abdalla Rasheed, Vinícius Remus Ballotin, Lucas Goldmann Bigarella, Jonathan Soldera","doi":"10.5662/wjm.v13.i4.296","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The coronavirus disease 2019 (COVID-19) pandemic has had a profound impact on global health, primarily characterized by severe respiratory illness. However, emerging evidence suggests that COVID-19 can also lead to secondary sclerosing cholangitis (SC), referred to as post-COVID-19 cholangiopathy.</p><p><strong>Aim: </strong>To synthesize currently reported cases to assess the current state of knowledge on post-COVID-19 cholangiopathy.</p><p><strong>Methods: </strong>Medical Subject Headings and Health Sciences Descriptors were used to retrieve relevant studies, which were combined using Boolean operators. Searches were conducted on electronic databases including Scopus, Web of Science, and MEDLINE (PubMed). Studies published in English, Spanish, or Portuguese were included, with no restrictions on the publication date. Additionally, the reference lists of retrieved studies were manually searched. Simple descriptive analyses were used to summarize the results. Then the data were extracted and assessed based on Reference Citation Analysis (https://www.referencecitationanalysis.com/).</p><p><strong>Results: </strong>The initial search yielded a total of 192 articles. After screening, 85 articles were excluded due to duplication, leaving 107 articles for further review. Of these, 63 full-length articles met the inclusion criteria and were included in the analyses. Most of the patients were male and exhibited elevated liver function tests (93.8%). Magnetic resonance imaging revealed duct thickening with contrast enhancement (47.7%), as well as beading of the intrahepatic ducts (45.7%) with peribiliary contrast enhancement on diffusion (28.7%). Liver biopsy results confirmed SC in most cases (74.4%). Sixteen patients underwent liver transplantation, with three experiencing successful outcomes.</p><p><strong>Conclusion: </strong>Post-COVID-19 cholangiopathy is a serious condition that is expected to become increasingly concerning in the coming years, particularly considering long COVID syndromes. Although liver transplantation has been proposed as a potential treatment option, more research is necessary to establish its efficacy and explore other potential treatments.</p>","PeriodicalId":94271,"journal":{"name":"World journal of methodology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0f/7c/WJM-13-296.PMC10523251.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of methodology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5662/wjm.v13.i4.296","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The coronavirus disease 2019 (COVID-19) pandemic has had a profound impact on global health, primarily characterized by severe respiratory illness. However, emerging evidence suggests that COVID-19 can also lead to secondary sclerosing cholangitis (SC), referred to as post-COVID-19 cholangiopathy.
Aim: To synthesize currently reported cases to assess the current state of knowledge on post-COVID-19 cholangiopathy.
Methods: Medical Subject Headings and Health Sciences Descriptors were used to retrieve relevant studies, which were combined using Boolean operators. Searches were conducted on electronic databases including Scopus, Web of Science, and MEDLINE (PubMed). Studies published in English, Spanish, or Portuguese were included, with no restrictions on the publication date. Additionally, the reference lists of retrieved studies were manually searched. Simple descriptive analyses were used to summarize the results. Then the data were extracted and assessed based on Reference Citation Analysis (https://www.referencecitationanalysis.com/).
Results: The initial search yielded a total of 192 articles. After screening, 85 articles were excluded due to duplication, leaving 107 articles for further review. Of these, 63 full-length articles met the inclusion criteria and were included in the analyses. Most of the patients were male and exhibited elevated liver function tests (93.8%). Magnetic resonance imaging revealed duct thickening with contrast enhancement (47.7%), as well as beading of the intrahepatic ducts (45.7%) with peribiliary contrast enhancement on diffusion (28.7%). Liver biopsy results confirmed SC in most cases (74.4%). Sixteen patients underwent liver transplantation, with three experiencing successful outcomes.
Conclusion: Post-COVID-19 cholangiopathy is a serious condition that is expected to become increasingly concerning in the coming years, particularly considering long COVID syndromes. Although liver transplantation has been proposed as a potential treatment option, more research is necessary to establish its efficacy and explore other potential treatments.
背景:2019冠状病毒病(新冠肺炎)大流行对全球健康产生了深远影响,主要表现为严重的呼吸道疾病。然而,新出现的证据表明,新冠肺炎也可能导致继发性硬化性胆管炎(SC),即新冠肺炎后胆道病。目的:综合目前报告的病例,以评估COVID-19后胆道病的知识现状。方法:使用医学主题标题和健康科学描述符检索相关研究,并使用布尔运算符进行组合。在Scopus、Web of Science和MEDLINE(PubMed)等电子数据库上进行了搜索。包括以英语、西班牙语或葡萄牙语发表的研究,对发表日期没有限制。此外,还手动搜索检索到的研究的参考文献列表。使用简单的描述性分析来总结结果。然后根据参考文献引文分析对数据进行提取和评估(https://www.referencecitationanalysis.com/)。结果:初步搜索共产生192篇文章。经过筛选,有85篇文章因重复而被排除在外,剩下107篇文章有待进一步审查。其中,63篇长篇文章符合纳入标准并被纳入分析。大多数患者为男性,肝功能测试升高(93.8%)。磁共振成像显示肝内导管增厚伴造影增强(47.7%),肝内导管珠状突起(45.7%)伴胆管周围扩散增强(28.7%)。肝活检结果证实大多数病例(74.4%)为SC。16名患者接受了肝移植,其中三个取得了成功。结论:COVID-19后胆道病是一种严重的疾病,预计在未来几年将变得越来越令人担忧,特别是考虑到长期COVID综合征。尽管肝移植已被认为是一种潜在的治疗选择,但还需要更多的研究来确定其疗效并探索其他潜在的治疗方法。